E-LIB Suche - Ergebnisse für: Livi, L.

1

The observational clinical registry (cohort design) of the ..:

Trama A ; Licitra L ; Cavalieri S...
info:eu-repo/semantics/altIdentifier/pmid/36928072. , 2023

Link: https://hdl.handle.net/2..

2

The observational clinical registry (cohort design) of the ..:

Trama A ; Licitra L ; Cavalieri S...
info:eu-repo/semantics/altIdentifier/pmid/36928072. , 2023

Link: https://hdl.handle.net/1..

3

Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibit..:

Becherini, C ; Visani, L ; Caini, S...
ARTN 102586. , 2023

Link: https://repository.icr.a..

4

Association between thyroid function and regorafenib effica..:

Caccese M ; Desideri I ; Bruno F...
info:eu-repo/semantics/altIdentifier/pmid/37264256. , 2023

Link: https://hdl.handle.net/1..

5

Adjuvant capecitabine in triple negative breast cancer pati..:

Di Lisa F. S ; Krasniqi E ; Pizzuti L...
info:eu-repo/semantics/altIdentifier/pmid/37260975. , 2023

Link: https://hdl.handle.net/1..

6

Adjuvant capecitabine in triple negative breast cancer pati..:

Di Lisa F. S ; Krasniqi E ; Pizzuti L...
info:eu-repo/semantics/altIdentifier/pmid/37260975. , 2023

Link: https://hdl.handle.net/1..

7

P106 De-escalation of radiation therapy after primary syste..:

M. Banini ; M. Valzano ; C. Becherini...
http://www.sciencedirect.com/science/article/pii/S0960977623002230. , 2023

Link: https://doi.org/10.1016/..

8

A case of metastic melanoma of IACs with a rapidly decay of..:

Donniacuo, A ; Livi, L ; Viberti, F..
info:eu-repo/semantics/altIdentifier/wos/WOS:001135409900001. , 2023

Link: https://hdl.handle.net/1..

9

Concomitant administration of proton pump inhibitors does n..:

Del Re M ; Crucitta S ; Omarini C...
info:eu-repo/semantics/altIdentifier/pmid/36283134. , 2022

Link: https://hdl.handle.net/1..

10

Real-world experience of abiraterone acetate plus prednison..:

Procopio, G ; Chiuri, V.E ; Giordano, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058899/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Real-world experience of abiraterone acetate plus prednison..:

Procopio, G ; Chiuri, V E ; Giordano, M...
info:eu-repo/semantics/altIdentifier/pmid/35405438. , 2022

Link: http://hdl.handle.net/11..

12

Controversial topics in metastatic HR+/HER2- breast cancer:..:

Fabi A ; Buono G ; Bria E...
volume:12. , 2022

Link: http://hdl.handle.net/11..

13

Reply to comments on: Drug-drug interactions between palboc..:

Del Re M ; Omarini C ; Diodati L...
info:eu-repo/semantics/altIdentifier/pmid/35131649. , 2022

Link: http://hdl.handle.net/11..

14

Reply to comments on: Drug-drug interactions between palboc..:

Del Re, M ; Omarini, C ; Diodati, L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897157/. , 2022

Link: http://www.ncbi.nlm.nih...

15

The prognostic relevance of HER2-positivity gain in metasta..:

Pizzuti L ; Barba M ; Mazzotta M...
info:eu-repo/semantics/altIdentifier/pmid/34215766. , 2021

Link: http://hdl.handle.net/10..